Imizol* (imidocarb diproprionate 12 per cent w/v) at 5 mg/kg body weight was found to be highly effective in the treatment of canine babesiosis, mixed infections of Babesia canis, Hepatozoon canis and Ehrlichia canis, but slightly less effective against uncomplicated Ehrlichia canis infections.